These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23862669)

  • 1. Deliberate hydroxycarbamide overdose in an adult with essential thrombocythaemia.
    Litt E; Thomas B; Smyth J; Desoysa L; Watson D
    Br J Haematol; 2013 Oct; 163(2):280-1. PubMed ID: 23862669
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of the European LeukaemiaNet criteria for clinicohaematological response and resistance/intolerance to hydroxycarbamide in essential thrombocythaemia.
    Hernández-Boluda JC; Alvarez-Larrán A; Gómez M; Angona A; Amat P; Bellosillo B; Martínez-Avilés L; Navarro B; Teruel A; Martínez-Ruiz F; Besses C
    Br J Haematol; 2011 Jan; 152(1):81-8. PubMed ID: 21083657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia.
    Francis S; Bareford D; Baggott C; Thachil J
    Leuk Res; 2012 Apr; 36(4):488-90. PubMed ID: 22196956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients.
    Besses C; Alvarez-Larrán A; Martínez-Avilés L; Mojal S; Longarón R; Salar A; Florensa L; Serrano S; Bellosillo B
    Br J Haematol; 2011 Feb; 152(4):413-9. PubMed ID: 21219298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea-induced foot ulcer in a case of essential thrombocythaemia.
    Tsuchiya S; Ichioka S; Sekiya N
    J Wound Care; 2010 Aug; 19(8):361-4. PubMed ID: 20852510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anagrelide: new drug. Essential thrombocythaemia: further evaluation needed for this last-resort treatment.
    Prescrire Int; 2006 Jun; 15(83):83-6. PubMed ID: 16764090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea therapy: a rare cause of reversible azoospermia.
    Masood J; Hafeez A; Hughes A; Barua JM
    Int Urol Nephrol; 2007; 39(3):905-7. PubMed ID: 17333529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double, suicidal intoxication with hydroxycarbamide--a case report.
    Waldman W; Kabata P; Sein Anand J
    Przegl Lek; 2012; 69(8):587-8. PubMed ID: 23243936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of low-dose aspirin and hydroxyurea on platelet-leukocyte interactions in patients with essential thrombocythemia.
    Treliński J; Tybura M; Smolewski P; Robak T; Chojnowski K
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):646-51. PubMed ID: 19741509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential thrombocythaemia: challenges and evidence-based management.
    Harrison CN
    Br J Haematol; 2005 Jul; 130(2):153-65. PubMed ID: 16029444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New consensus: a unified definition of clinical resistance and/or intolerance to hydroxyurea in essential thrombocythaemia.
    Barosi G
    Eur J Haematol Suppl; 2007 Oct; (68):24-6. PubMed ID: 17727562
    [No Abstract]   [Full Text] [Related]  

  • 12. [A lower-leg ulcer during hydroxyurea therapy for essential thrombocythemia].
    Iwama H; Kawakubo K; Nehashi Y; Kuriyama Y; Iwase O; Ohyashiki K; Watanabe K; Ebihara Y; Toyama K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):937-9. PubMed ID: 8678547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma following essential thrombocythemia.
    Ben Youssef Y; Gmidène A; Bouabid Z; Bouallegui S; Sriha B; Zaier M; Sennana H; Khelif A
    Ann Biol Clin (Paris); 2013; 71(4):457-60. PubMed ID: 23906574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary cutaneous effects of hydroxyurea: possible pathogenetic mechanisms.
    Zaccaria E; Cozzani E; Parodi A
    J Dermatolog Treat; 2006; 17(3):176-8. PubMed ID: 16854761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential thrombocythaemia.
    Mathew KK; Fernande G; Shenoy C
    J Indian Med Assoc; 2002 Apr; 100(4):247. PubMed ID: 12405336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential thrombocythaemia.
    Harrison CN; Green AR
    Best Pract Res Clin Haematol; 2006; 19(3):439-53. PubMed ID: 16781482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea in the treatment of Churg-Strauss syndrome.
    Lee RU; Stevenson DD
    J Allergy Clin Immunol; 2009 Nov; 124(5):1110-1. PubMed ID: 19703710
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera.
    Johansson P; Andréasson B
    Clin Lab Haematol; 2006 Aug; 28(4):233-6. PubMed ID: 16898960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myocardial infarction: an unusual presentation of essential thrombocytosis in a 17-year-old man.
    Kelly SV; Burke RF; Lee KS; Torloni AS; Lee RW; Northfelt D; Fonseca R
    Clin Adv Hematol Oncol; 2008 Feb; 6(2):133-6. PubMed ID: 18347564
    [No Abstract]   [Full Text] [Related]  

  • 20. Dermatomyositis-like eruption with long-term hydroxyurea.
    Elliott R; Davies M; Harmse D
    J Dermatolog Treat; 2006; 17(1):59-60. PubMed ID: 16467027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.